Suchergebnisse - "Yates, James W T"

PubPharm (4)

1

The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression

enthalten in: Molecular cancer therapeutics | 2018

von Wallez, Y. | Dunlop, C. | Johnson, T. | +7

2

Irreversible Inhibition of EGFR : Modeling the Combined Pharmacokinetic-Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104

enthalten in: Molecular cancer therapeutics | 2016

von Yates, J. | Ashton, S. | Cross, D. | +3

3

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

enthalten in: Molecular cancer therapeutics | 2015

von Guichard, S. | Curwen, J. | Bihani, T. | +15

4

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

enthalten in: Molecular cancer therapeutics | 2015

von Guichard, S. | Curwen, J. | Bihani, T. | +15

1
[1]